ProFunds Biotechnology UltraSector Svc BIPSX
- NAV / 1-Day Return 35.11 / +1.71 %
- Total Assets 115.9 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.540%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Trading—Leveraged Equity
- Investment Style Small Growth
- Min. Initial Investment 15,000
- Status Open
- TTM Yield —
- Turnover 91%
USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:09 PM GMT+0
Morningstar’s Analysis BIPSX
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 12.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Soc 5.18% , 2/1/2024 | 8.06 | 8.6 Mil | Cash and Equivalents |
Hsb 5.15% , 2/1/2024 | 4.84 | 5.2 Mil | Cash and Equivalents |
Cra 5.19% , 2/1/2024 | 4.03 | 4.3 Mil | Cash and Equivalents |
Ntm 5.18% , 2/1/2024 | 3.36 | 3.6 Mil | Cash and Equivalents |
Royal Bank of Canada 5.17% | 3.36 | 3.6 Mil | Cash and Equivalents |
Umb 5.1% , 2/1/2024 | 2.56 | 2.7 Mil | Cash and Equivalents |
Cytokinetics Inc | 2.05 | 2.2 Mil | Healthcare |
Karuna Therapeutics Inc | 1.37 | 1.5 Mil | Healthcare |
Sarepta Therapeutics Inc | 1.23 | 1.3 Mil | Healthcare |
Biohaven Ltd | 1.21 | 1.3 Mil | Healthcare |